InvestorsHub Logo
Followers 375
Posts 17004
Boards Moderated 4
Alias Born 03/07/2014

Re: elysse1kittycat post# 92824

Wednesday, 02/10/2016 9:30:16 AM

Wednesday, February 10, 2016 9:30:16 AM

Post# of 92948
You're welcome.

I just stick with SEC filings and the basics.

The magic stem cell bloggy site thingy- I've known of their bad antics for quite some time. That blog puts out two kinds of info- WRONG and REAL WRONG as far as I'm concerned.

That little magic cell blog is probably on its last legs, and rightfully so IMO.

They've posted fake share counts, impersonated attorneys, claimed to be doctors and lawyers and other fake roles. They post hype and false, mis-leading, grossly inaccurate info, via the same 3 or 4 people playing multi roles, under numerous different names. Heck, they even duped a Boston "reporter" into believing he was talking to a major shareholder- when he was just talking to the same old guy from the magic cell bloggy site, using a number to make it look like he'd called in from the supposed state in which that attorney showed as his last possible location in a SEC filing. BAD, BAD "stuff" at that little bloggy site.

The little magic cell blog has been 100% WRONG on pretty much everything they've ever stated regarding ACTC/OCATA- I really can't recall a single thing they've ever been correct about? Ever?

They operate as a FAKE LLC and all the rest- just terrible IMO how many people they so grossly have mislead over the years from just that one little bloggy site and its operator.

Well, they won't be misleading about OCATA anymore- it's in "good hands" now with Astellas who can fund and advance the good work of OCATA and of Lanza for years to come.

Posts contain only my amateur opinions, personal views and thoughts. I discuss stocks as a hobby only. Always do one's own due diligence before investing.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.